BCPC Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Balchem News
BCPC FAQ
What was Balchem’s price range in the past 12 months?
Currently, no data Available
What is Balchem’s market cap?
Balchem’s market cap is $91.46B.
When is Balchem’s upcoming earnings report date?
Balchem’s upcoming earnings report date is Oct 23, 2026 which is in 90 days.
How were Balchem’s earnings last quarter?
Currently, no data Available
Is Balchem overvalued?
According to Wall Street analysts Balchem’s price is currently Undervalued.
Does Balchem pay dividends?
Balchem does not currently pay dividends.
What is Balchem’s EPS estimate?
Balchem’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Balchem have?
Currently, no data Available
What happened to Balchem’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Balchem?
Currently, no hedge funds are holding shares in MX:BCPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Balchem Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3,711.87 (― Downside)
$3,711.87 (― Downside)
Blogger Sentiment
Bullish
MX:BCPC Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
4.71%
Trailing 12-Months
Company Description
Balchem
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
BCPC Stock 12 Month Forecast
Average Price Target
$3,711.87
